Efg Asset Management (North America) Corp. Rhythm Pharmaceuticals, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $724 Million
- Q3 2025
A detailed history of Efg Asset Management (North America) Corp. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 20,269 shares of RYTM stock, worth $2.01 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
20,269Holding current value
$2.01 Million% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
282Shares Held
486MCall Options Held
498KPut Options Held
150K-
Perceptive Advisors LLC New York, NY419MShares$41.7 Billion94.44% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$670 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.68MShares$565 Million9.85% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$557 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA5MShares$497 Million0.01% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.54B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...